Sakar Healthcare Limited Cash Flow Conversion Efficiency
Sakar Healthcare Limited cash flow conversion efficiency. Based on the latest financial reports, Sakar Healthcare Limited (SAKAR) has a cash flow conversion efficiency ratio of 0.101x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs305.87 Million ≈ $3.31 Million USD) by net assets (Rs3.03 Billion ≈ $32.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Sakar Healthcare Limited (2010–2026)
Cash flow conversion efficiency of Sakar Healthcare Limited from 2010 to 2026. This chart illustrates how Sakar Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Sakar Healthcare Limited (SAKAR) share price today for real-time trading data and today's change.
Sakar Healthcare Limited Cash Flow Conversion Ratio Explained
Sakar Healthcare Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Sakar Healthcare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sakar Healthcare Limited ranked by their cash flow conversion efficiency. Also see SAKAR market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
E. W. Scripps Co Class A
NASDAQ:SSP
|
0.135x |
|
Sinocat Environmental Technology Co Ltd
SHG:688737
|
-0.005x |
|
Ace Pillar Co Ltd
TW:8374
|
0.032x |
|
Columbus Circle Capital Corp III Class A Ordinary Shares
NASDAQ:CCCT
|
N/A |
|
Xinjiang Youhao Group Co Ltd
SHG:600778
|
0.268x |
|
Jiangxi Haiyuan Composites Technology Co Ltd
SHE:002529
|
0.566x |
|
MAKUS Inc
KQ:093520
|
0.021x |
|
Baoding Dongli Machinery Co.Ltd.
SHE:301298
|
N/A |
Annual Cash Flow Conversion Efficiency for Sakar Healthcare Limited (2010–2026)
The table below shows the annual cash flow conversion efficiency of Sakar Healthcare Limited from 2010 to 2026. Review Sakar Healthcare Limited free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs3.24 Billion ≈ $35.09 Million |
Rs393.71 Million ≈ $4.26 Million |
0.121x | +1.79% |
| 2025-03-31 | Rs2.85 Billion ≈ $30.87 Million |
Rs340.32 Million ≈ $3.68 Million |
0.119x | +27.82% |
| 2024-03-31 | Rs2.62 Billion ≈ $28.37 Million |
Rs244.67 Million ≈ $2.65 Million |
0.093x | -54.22% |
| 2023-03-31 | Rs1.73 Billion ≈ $18.75 Million |
Rs353.14 Million ≈ $3.82 Million |
0.204x | -27.26% |
| 2022-03-31 | Rs1.27 Billion ≈ $13.78 Million |
Rs356.99 Million ≈ $3.86 Million |
0.280x | +89.16% |
| 2021-03-31 | Rs984.52 Million ≈ $10.65 Million |
Rs145.77 Million ≈ $1.58 Million |
0.148x | +18.92% |
| 2020-03-31 | Rs813.20 Million ≈ $8.79 Million |
Rs101.25 Million ≈ $1.09 Million |
0.125x | -53.27% |
| 2019-03-31 | Rs717.04 Million ≈ $7.75 Million |
Rs191.03 Million ≈ $2.07 Million |
0.266x | +160.56% |
| 2018-03-31 | Rs514.93 Million ≈ $5.57 Million |
Rs52.65 Million ≈ $569.38K |
0.102x | +18606825.53% |
| 2017-03-31 | Rs355.03 Million ≈ $3.84 Million |
Rs195.09 ≈ $2.11 |
0.000x | -88.53% |
| 2016-03-31 | Rs191.82 Million ≈ $2.07 Million |
Rs918.64 ≈ $9.93 |
0.000x | -100.00% |
| 2015-03-31 | Rs148.28 Million ≈ $1.60 Million |
Rs41.76 Million ≈ $451.59K |
0.282x | -54.40% |
| 2014-03-31 | Rs138.71 Million ≈ $1.50 Million |
Rs85.67 Million ≈ $926.46K |
0.618x | +13.02% |
| 2013-03-31 | Rs121.19 Million ≈ $1.31 Million |
Rs66.23 Million ≈ $716.22K |
0.546x | +160.66% |
| 2012-03-31 | Rs137.59 Million ≈ $1.49 Million |
Rs28.84 Million ≈ $311.95K |
0.210x | +1.82% |
| 2011-03-31 | Rs132.75 Million ≈ $1.44 Million |
Rs27.33 Million ≈ $295.59K |
0.206x | +2334.89% |
| 2010-03-31 | Rs123.53 Million ≈ $1.34 Million |
Rs-1.14 Million ≈ $-12.31K |
-0.009x | -- |
About Sakar Healthcare Limited
Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as anti-infective, analge… Read more